Viatris Inc. (NASDAQ: VTRS), a US-based global healthcare company, announced on Monday that it has named Corinne Le Goff as its new chief commercial officer and a member of the company's executive leadership team, effective immediately.

Le Goff, a biotechnology and pharmaceutical executive, has over 25 years of experience leading and building highly successful teams globally. She has served as president and chief executive officer of Imunon and chief commercial officer at Moderna. She has also spent six years of her career at Amgen, where she served as president of the U.S. Business, senior vice president of Global Product Strategy & Commercial Innovation and as president of the Europe Region.

Viatris CEO Scott A Smith said, 'I believe Corinne has the skills and experience to help further propel our growth and position Viatris for long-term success, building on the great talent I have seen across our existing commercial organisation since joining a year ago. Corinne is a talented healthcare executive with a deep understanding of the pharmaceutical and biotech industries, including multiple therapeutic areas, markets and geographies. I look forward to welcoming her to Viatris and to working closely with her as we continue to build the truly unique company we have envisioned.'